GATA6 and hepatocellular carcinoma: These findings suggest that BCL11B expression in HCC might be the potential therapeutic target; however, further studies focusing on the direct relationship between BCL11B and GATA6 using Bcl11b conditional knockout mice and its contribution in HCC pathology are essential.